AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

11276	Companies
250575	Keywords
179213	Articles
136415	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 10/29/2025 at 08:00, 1 year ago

Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared

AMOEBA Regulatory Framework Market Authorization AXPERA Vineyard Trial
PRESS RELEASE

published on 10/29/2025 at 08:00, 1 year ago

Amoéba présente le bilan 2025 de sa campagne d'essais viticoles : AXPERA confirme son efficacité contre le mildiou et sa capacité à réduire fortement l'usage du cuivre
Amoéba présente les résultats des essais viticoles 2025 pour AXPERA, confirmant son efficacité contre le mildiou. Cadre réglementaire durci en France, démarches d'homologation en cours pour commercialisation en 2026

AMOEBA Homologation AXPERA Mildiou Essais Viticoles
BRIEF

published on 10/24/2025 at 18:05, 1 year ago

Amoéba Publie son Rapport Financier Semestriel

AMOEBA Biocontrôle Cosmétique Rapport Financier Amibes Brevetées
BRIEF

published on 10/24/2025 at 18:05, 1 year ago

Amoéba Publishes its Half-Yearly Financial Report

AMOEBA Financial Report Biocontrol Cosmetic Patented Amoebas
PRESS RELEASE

published on 10/24/2025 at 18:00, 1 year ago

Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website

AMOEBA French Financial Markets Authority Half-year Financial Report GreenTech Microbiological Solutions
PRESS RELEASE

published on 10/24/2025 at 18:00, 1 year ago

Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2025
Amoéba publie son rapport financier semestriel au 30 juin 2025 auprès de l'AMF. Greentech développant des solutions microbiologiques naturelles. Informations consultables sur leur site

AMOEBA AMF Rapport Financier GreenTech Microbiologique
BRIEF

published on 10/20/2025 at 18:35, 1 year ago

AXPERA primée pour son innovation en biocontrôle

AMOEBA Biocontrôle Innovation Environnement AXPERA
BRIEF

published on 10/20/2025 at 18:35, 1 year ago

AXPERA awarded for its innovation in biocontrol

AMOEBA Innovation Biocontrol Environment AXPERA
PRESS RELEASE

published on 10/20/2025 at 18:30, 1 year ago

AXPERA désignée solution de biocontrôle de l'année 2025 // L'innovation anti-maladies fongiques d'Amoéba remporte le prix " Gold " du " Bernard Blum " Award 2025
Amoéba remporte la médaille d'or du prestigieux prix Bernard Blum pour sa solution AXPERA. Une reconnaissance mondiale de l'innovation en biocontrôle

AMOEBA Biocontrôle Innovation AXPERA Bernard Blum Award
PRESS RELEASE

published on 10/20/2025 at 18:30, 1 year ago

AXPERA named biocontrol solution of the year 2025 // Amoeba's anti-fungal innovation wins the Gold Award at the 2025 Bernard Blum Awards
Amoéba wins prestigious Bernard Blum Gold Medal for innovation in biocontrol with AXPERA, a natural microbiological solution based on amoebae, offering plant protection against fungal diseases. Award highlights Amoéba's excellence in sustainable agriculture

AMOEBA Sustainable Agriculture Biocontrol AXPERA Bernard Blum Gold Medal

Accesswire

Published on 11/04/2026 at 23:10, 30 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 40 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 40 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 1 hour 25 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 1 hour 35 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/04/2026 at 19:41, 3 hours 58 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 4 hours 14 minutes ago

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 4 hours 57 minutes ago

EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 5 hours 34 minutes ago

Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 17:40, 6 hours ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.26.

Les Echos

Published on 11/04/2026 at 18:00, 5 hours 39 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 5 hours 39 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 5 hours 55 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 5 hours 55 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 5 hours 56 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE